The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation
Abstract
BACKGROUND: The objectives of this study were to clarify risk factors for local tumor recurrence and to determine which patients with hepatocellular carcinoma (HCC) are most suitable for a single session, single application of percutaneous radiofrequency (RF) ablation. METHODS: Fifty‐six consecutive patients with 65 HCC tumors measuring ≤ 3 cm in greatest dimension who received a single session, single application of percutaneous RF ablation and who achieved optimal tumor ablation, as assessed by an immediate computed tomography scan, were enrolled in this study. Six possible factors for local recurrence were analyzed using a Cox proportional hazards regression model: tumor size, tumor location, proximity of the tumor to intrahepatic large vessels, types of electrodes used, prior treatment, and observation of impedance rises. Local recurrence free intervals were estimated using the Kaplan–Meier method, and differences between groups were compared using the log‐rank test. RESULTS: The Kaplan–Meier estimates of overall cumulative local recurrence free intervals after a single RF ablation treatment were 76% (95% confidence interval [95%CI], 70.9–81.7%) at 12 months and 74% (95%CI, 68.2–79.6%) at 15 months. The log‐rank test revealed a statistically significant difference between the local recurrence free intervals according to tumor size (P = 0.001) and tumor location (P < 0.001). Further investigation with a Cox regression analysis indicated that a greatest tumor dimension > 2 cm (risk ratio [RR], 4.9; 95%CI, 1.3–16.4; P = 0.019) and subcapsular location (RR, 5.2; 95%CI, 1.7–16.6; P = 0.005) were associated independently with local recurrence. The other four factors were not associated with local recurrence in this study. CONCLUSIONS: A single session, single application of RF ablation produced favorable local control. Patients who have nonsubcapsular HCC tumors measuring ≤ 2 cm in greatest dimension may be the most suitable candidates for a single‐session, single application of RF ablation. Cancer 2003;97:1253–62. © 2003 American Cancer Society. DOI 10.1002/cncr.11168
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941 · cited 1×
“Thirty-three patients (59%) were classified with Child–Pugh Class A disease; 21 patients (38%) were classified with Class B disease; and 2 patients (3%) were classified with Class C disease.(19)”
BackgroundSmall Hepatocellular Carcinoma: Treatment with Radio-frequency Ablation versus Ethanol Injection
Livraghi, T., Goldberg, S. N., Lazzaroni, S., Meloni, F., Solbiati, L., & Gazelle, G. S. (1999) · Radiology · doi:10.1148/radiology.210.3.r99fe40655 · Cited by 1,283
Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease
Tsukuma, H., Hiyama, T., Tanaka, S., Nakao, M., Yabuuchi, T., Kitamura, T., Nakanishi, K., Fujimoto, I., Inoue, A., Yamazaki, H., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282501 · Cited by 1,126
Hepatocellular Carcinoma: Radio-frequency Ablation of Medium and Large Lesions
Livraghi, T., Goldberg, S. N., Lazzaroni, S., Meloni, F., Ierace, T., Solbiati, L., & Gazelle, G. S. (2000) · Radiology · doi:10.1148/radiology.214.3.r00mr02761 · Cited by 1,013
Llovet, J. M., Vilana, R., Brú, C., Bianchi, L., Salmeron, J. M., Boix, L., Ganau, S., Sala, M., Pagès, M., Ayuso, C., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.24233 · Cited by 759
Radiofrequency Ablation of Hepatocellular Cancer in 110 Patients With Cirrhosis
Curley, S. A., Izzo, F., Ellis, L. M., Nicolas Vauthey, J., & Vallone, P. (2000) · Annals of Surgery · doi:10.1097/00000658-200009000-00010 · Cited by 731
Poon, R. T.-P., Fan, S.-T., Ng, I. O.-L., Lo, C.-M., Liu, C.-L., & Wong, J. (2000) · Cancer · doi:10.1002/1097-0142(20000801)89:3<500::aid-cncr4>3.0.co;2-o · Cited by 729
Radiofrequency Ablation of the Liver: Current Status
McGahan, J. P., & Dodd, G. D. (2001) · American Journal of Roentgenology · doi:10.2214/ajr.176.1.1760003 · Cited by 583
Goldberg, S. N., Hahn, P. F., Tanabe, K. K., Mueller, P. R., Schima, W., Athanasoulis, C. A., Compton, C. C., Solbiati, L., & Gazelle, G. S. (1998) · Journal of Vascular and Interventional Radiology · doi:10.1016/s1051-0443(98)70491-9 · Cited by 555
Rossi, S., Garbagnati, F., Lencioni, R., Allgaier, H.-P., Marchianò, A., Fornari, F., Quaretti, P., Tolla, G. D., Ambrosi, C., Mazzaferro, V., et al. (2000) · Radiology · doi:10.1148/radiology.217.1.r00se02119 · Cited by 489
Okuda, K. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80428-6 · Cited by 443
Cady, B., Jenkins, R. L., Steele, G. D., Lewis, W. D., Stone, M. D., McDermott, W. V., Jessup, J. M., Bothe, A., Lalor, P., Lovett, E. J., et al. (1998) · Annals of Surgery · doi:10.1097/00000658-199804000-00019 · Cited by 423
Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients.
Shiina, S., Tagawa, K., Niwa, Y., Unuma, T., Komatsu, Y., Yoshiura, K., Hamada, E., Takahashi, M., Shiratori, Y., & Terano, A. (1993) · American Journal of Roentgenology · doi:10.2214/ajr.160.5.7682378 · Cited by 370
Castells, A., Bruix, J., Bru, C., Fuster, J., Vilana, R., Navasa, M., Ayuso, C., Boix, L., Visa, J., & Rodés, J. (1993) · Hepatology · doi:10.1002/hep.1840180517 · Cited by 368
Significance of Resection Margin in Hepatectomy for Hepatocellular Carcinoma: A Critical Reappraisal
Poon, R. T.-P., Fan, S.-T., Ng, I. O.-L., & Wong, J. (2000) · Annals of Surgery · doi:10.1097/00000658-200004000-00014 · Cited by 357
Livraghi, T., Bolondi, L., Buscarini, L., Cottone, M., Mazziotti, A., Morabito, A., & Torzilli, G. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80445-5 · Cited by 278
Treatment of Hepatocellular Carcinoma
Bruix, J. (1997) · Hepatology · doi:10.1002/hep.510250201 · Cited by 277
Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans
Kutami, R., Nakashima, Y., Nakashima, O., Shiota, K., & Kojiro, M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80369-4 · Cited by 249
Hanazaki, K., Kajikawa, S., Shimozawa, N., Mihara, M., Shimada, K., Hiraguri, M., Koide, N., Adachi, W., & Amano, J. (2000) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(00)00700-6 · Cited by 225
Sergi, C., Adam, S., Kahl, P., & Otto, H. F. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)81188-5 · Cited by 189
Cited by
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“In addition, HCC tumors in a subcapsular location or adjacent to the gallbladder have a higher risk of incomplete ablation [275] or major complications [268,276,277].”
BackgroundEASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
(2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.021 · Cited by 1,096
Mulier, S., Ni, Y., Jamart, J., Ruers, T., Marchal, G., & Michel, L. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000171032.99149.fe · Cited by 688
Lin, S.-M., Lin, C.-J., Lin, C.-C., Hsu, C.-W., & Chen, Y.-C. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.003 · Cited by 609
Lin, S.-M., Lin, C.-J., Lin, C.-C., Hsu, C.-W., & Chen, Y.-C. (2005) · Gut · doi:10.1136/gut.2004.045203 · Cited by 592
Metadata
- Authors
- Komorizono, Y., Oketani, M., Sako, K., Yamasaki, N., Shibatou, T., Maeda, M., Kohara, K., Shigenobu, S., Ishibashi, K., & Arima, T.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2003-02-20
- Volume
- 97
- Issue
- 5
- Pages
- 1253-1262
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1984471249
- Cited by
- 336
- References
- 20
- FWCI
- 8.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.